EARLY BIRD DISCOUNT! Register by February 5, 2017 to receive 20% off your registration!
Or Register 3 for the price of 2 with the coupon code rcdvb!
registration button

14th Stem Cell Research & Regenerative Medicine
6th Stem Cell Product Development & Commercialization
GTCbio offers comprehensive sponsorship packages for all our meetings, including presentation opportunities, exhibit and booth space, as well as the event delegate list. All our packages can be customized to meet your company's budget. For information, please contact:

Amber Kempf
626-256-6405 x110
amber.kempf [at] gtcbio.com

GTCbio encourages attendees to showcase their research at the conference by presenting a poster. The top 2-3 submitted posters will also be selected to give short oral presentations as part of the meeting program. Abstracts will be accepted until February 5, 2017; slots fill up quickly so submit yours online ASAP!

Speakers | Agenda | Venue | Sponsors | Poster Submissions

Dear Colleague,

GTCbio is proud to present the Stem Cell Summit 2017, to be held on April 5-7, 2017 in Boston, MA. GTCbio's Stem Cell Summit provides cutting-edge information on developments in all areas of stem cell research from bench to bedside, including the biology, medicine, applications, regulations, product development, and the commercialization of stem cells.

Recent developments in pre-clinical and clinical trials of stem cell therapy, regenerative medicine and tissue engineering, cancer stem cells, immunotherapy, stem cell reprogramming, regulatory policies regarding stem cell research, and manufacturing will all be discussed. Business opportunities, challenges, and potential strategies for overcoming these challenges will also be addressed. Come join us to learn what categories of companies are currently commercially viable, how they're being funded, and what kind of strategic relationships are available within the industry!

Stem Cell Summit 2017 includes two back-to-back conferences including joint plenary session

Conference 1: 14th Stem Cell Research & Regenerative Medicine

  1. Advances in Adult & Pluripotent Stem Cell Research
  2. Revolution in Immunotherapy
  3. Translation to the Clinic: What's in the Pipeline

Joint: Plenary Session

  1. Where do We Stand with Stem Cell Therapy in Diabetes?

Conference 2: 6th Stem Cell Product Development & Commercialization

  1. Stem Cells for Drug Discovery & Disease Modeling
  2. Regulatory Challenges in Cell Therapy
  3. Manufacturing and Scalable Processes
  4. Commercialization: Creating Sustainable Business Models
  5. Funding and Partnering
  6. Frontiers in Tissue Engineering

We hope to see you there!

Best regards,

The 2017 Advisory Committee

2017 Advisory Board Members
Stephen Chang, The New York Stem Cell Foundation
Douglas Losordo, Caladrius Biosciences
Robert Deans, Rubius Therapeutics
Alain Vertes, NxR Biotechnologies GmbH
Daniel Anderson, Massachusetts Institute of Technology
Edward Lanphier, Sangamo Biosciences
Khalid Shah, Harvard Medical School; Massachusetts General Hospital
Yang (Ted) Teng, Harvard University & The Brigham and Women's Hospital
James Ankrum, University of Iowa
Hardy T S Kagimoto, Healios K.K (RIKEN Venture)
Robert Halliwell, University of the Pacific
Devyn Smith, Pfizer
Jiwen Zhang, GE Healthcare
Julie G. Allickson, Wake Forest Institute for Regenerative Medicine
Tiina Palomaki, Finnish Medicines Agency
Satish Medicetty, GTCbio



Attend all GTCbio Conferences for one year for only $4,995 ($2,495 for academic and government).
Click here to sign up!

stem-cell-summit Overview